Medical treatment of diabetic foot infections

被引:273
作者
Lipsky, BA
机构
[1] VA Puget Sound Hlth Care Syst, Gen Internal Med Clin, Seattle, WA 98108 USA
[2] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
关键词
D O I
10.1086/383271
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Diabetic foot infections frequently cause morbidity, hospitalization, and amputations. Gram-positive cocci, especially staphylococci and also streptococci, are the predominant pathogens. Chronic or previously treated wounds often yield several microbes on culture, including gram-negative bacilli and anaerobes. Optimal culture specimens are wound tissue taken after debridement. Infection of a wound is defined clinically by the presence of purulent discharge or inflammation; systemic signs and symptoms are often lacking. Only infected wounds require antibiotic therapy, and the agents, route, and duration are predicated on the severity of infection. Mild to moderate infections can usually be treated in the outpatient setting with oral agents; severe infections require hospitalization and parenteral therapy. Empirical therapy must cover gram-positive cocci and should be broad spectrum for severe infections. Definitive therapy depends on culture results and the clinical response. Bone infection is particularly difficult to treat and often requires surgery. Several adjuvant agents may be beneficial in some cases.
引用
收藏
页码:S104 / S114
页数:11
相关论文
共 89 条
[61]   UNSUSPECTED OSTEOMYELITIS IN DIABETIC FOOT ULCERS - DIAGNOSIS AND MONITORING BY LEUKOCYTE SCANNING WITH INDIUM IN-111 OXYQUINOLINE [J].
NEWMAN, LG ;
WALLER, J ;
PALESTRO, CJ ;
SCHWARTZ, M ;
KLEIN, MJ ;
HERMANN, G ;
HARRINGTON, E ;
HARRINGTON, M ;
ROMAN, SH ;
STAGNAROGREEN, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (09) :1246-1251
[62]   Systematic review of antimicrobial agents used for chronic wounds [J].
O'Meara, SM ;
Cullum, NA ;
Majid, M ;
Sheldon, TA .
BRITISH JOURNAL OF SURGERY, 2001, 88 (01) :4-21
[63]   Enhanced neutrophil functions by recombinant human granulocyte colony-stimulating factor in diabetic patients with foot infections in vitro [J].
Peck, KR ;
Son, DW ;
Song, JH ;
Kim, S ;
Oh, MD ;
Choe, KW .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (01) :39-44
[64]   CHRONOLOGY AND DETERMINANTS OF TISSUE-REPAIR IN DIABETIC LOWER-EXTREMITY ULCERS [J].
PECORARO, RE ;
AHRONI, JH ;
BOYKO, EJ ;
STENSEL, VL .
DIABETES, 1991, 40 (10) :1305-1313
[65]   THERAPY OF LOWER-EXTREMITY INFECTIONS WITH CIPROFLOXACIN IN PATIENTS WITH DIABETES-MELLITUS, PERIPHERAL VASCULAR-DISEASE, OR BOTH [J].
PETERSON, LR ;
LISSACK, LM ;
CANTER, K ;
FASCHING, CE ;
CLABOTS, C ;
GERDING, DN .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (06) :801-808
[66]   Outcome of diabetic foot infections treated conservatively -: A retrospective cohort study with long-term follow-up [J].
Pittet, D ;
Wyssa, B ;
Herter-Clavel, C ;
Kursteiner, K ;
Vaucher, J ;
Lew, PD .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (08) :851-856
[67]   The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb [J].
Raymakers, JT ;
Houben, AJ ;
van der Heyden, JJ ;
Tordoir, JH ;
Kitslaar, PJ ;
Schaper, NC .
DIABETIC MEDICINE, 2001, 18 (03) :229-234
[68]  
Rayman A., 1998, DIABETIC FOOT, V1, P7
[69]   Identification of bacteria from a non-healing diabetic foot wound by 16 S rDNA sequencing [J].
Redkar, R ;
Kalns, J ;
Butler, W ;
Krock, L ;
McCleskey, F ;
Salmen, A ;
Piepmeier, E ;
DelVecchio, V .
MOLECULAR AND CELLULAR PROBES, 2000, 14 (03) :163-169
[70]   RISK-FACTORS FOR AMPUTATION IN PATIENTS WITH DIABETES-MELLITUS - A CASE-CONTROL STUDY [J].
REIBER, GE ;
PECORARO, RE ;
KOEPSELL, TD .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) :97-105